Sepsis & infection

Blood pressure response index trajectories identify distinct hemodynamic phenotypes and predict mortality in septic shock: a two-database retrospective cohort study

Crit CarePublished Retrospective cohort study

Authors' conclusion

BPRI trajectory analysis identifies six hemodynamic phenotypes in septic shock that are validated in an independent external database, are independently associated with mortality, and capture temporal hemodynamic response patterns missed by static assessments.

Study context

Population
Septic shock patients on vasopressor therapy, MIMIC-IV (development) and eICU-CRD (validation)1,240 eICU-CRD validation
Participants
4,389 patients
Exposure
BPRI trajectory phenotypes and ICU mortality
Outcome
ICU mortality by BPRI trajectory phenotype (first 48 h of vasopressor therapy)
Methodological detailstwo-database, latent class mixed models, external validation (parameter transport)
  • Two-database
  • Latent class mixed models
  • External validation (parameter transport)

Main finding

As reported in the abstract

ICU mortality
After full multivariable adjustment
Odds ratio (95% CI)
C2
3.67(2.76–4.86)
C1
2.68(2.08–3.46)

Observational data: associations, not effects.

Further findings

OutcomeΔAUCP value
Incremental discrimination beyond severity scoresSeverity scores + trajectory classification vs Severity scores · static BPRI added no further information+ 0.020P < 0.001

External validation (eICU-CRD)

Preserved class separation and prognostic gradient; average posterior probability
0.960

Restricted mean survival time, adjusted loss for C2 · τ = 14 days

Largest adjusted loss, C2 (minimal attenuation from unadjusted)
- 2.56 days

Original publication

Blood pressure response index trajectories identify distinct hemodynamic phenotypes and predict mortality in septic shock: a two-database retrospective cohort study. Crit Care. Published 29 April 2026. doi:10.1186/s13054-026-06059-w

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.